• Issues
    • Current Issue
    • Special Issues
  • Viewpoints
    • Editor’s Corner
    • Advanced Practice Voices
    • From Our Readers
      • You Make the Call: Readers’ Response
      • Guest Commentary
      • Letters to the Editor
    • A Day in the Life
    • Notes From the Hill
    • The Break Room
  • Education
    • You Make the Call
    • How I Teach
    • How I Treat In Brief
    • Demystifying the Lab
    • Practice Update
  • Spotlight
    • Feature Articles
    • Pulling Back the Curtain
    • Blood Beyond Borders
    • pASHions
    • Drawing First Blood
    • Interviews
  • News
    • Online Exclusives
    • Latest & Greatest
    • From the Blood Journals
      • Written in Blood
      • Blood Advances in a Different Vein
    • Literature Scan
    • ASH Directions
    • The Society Pages
  • Topic Compilations
    • COVID-19 News
    • Acute Leukemias
    • Chronic Leukemias
    • MDS & Myeloproliferative Neoplasms
    • Multiple Myeloma & Plasma Cell Disorders
    • Lymphomas & Lymphoid Neoplasia
    • Bleeding Disorders
    • Clotting Disorders
    • Red Blood Cell & Iron Disorders
  • On Location
    • ASH Annual Meeting
    • ASH Meeting on Hematologic Malignancies
    • ASH Meeting on Lymphoma Biology
    • Other Meetings
  • Multimedia
    • Sound Bites
    • Meeting Coverage
Search
  • ASH Home
  • About ASH Clinical News
  • Authors
  • Advertising
  • Subscribe
  • Contact Us
  • eNewsletters
  • Cookie Settings
  • LOG IN
Welcome! Log into your account
Forgot your password?
Recover your password
ASH Clinical News
  • Issues
    • AllCurrent IssueSpecial Issues

      January 2021 Annual Meeting Edition

      January 2021 Volume 7 Issue 1

      December 2020, Volume 6, Issue 15

      November 2020 Bonus ASH Annual Meeting Preview Edition (Volume 6, Issue…

  • Viewpoints
    • Editor’s Corner
    • Advanced Practice Voices
    • From Our Readers
      • You Make the Call: Readers’ Response
      • Guest Commentary
      • Letters to the Editor
    • A Day in the Life
    • Notes From the Hill
    • The Break Room
  • Education
    • You Make the Call
    • How I Teach
    • How I Treat In Brief
    • Demystifying the Lab
    • Practice Update
  • Spotlight
    • Feature Articles
    • Pulling Back the Curtain
    • Blood Beyond Borders
    • pASHions
    • Drawing First Blood
    • Interviews
  • News
    • Online Exclusives
    • Latest & Greatest
    • From the Blood Journals
      • Written in Blood
      • Blood Advances in a Different Vein
    • Literature Scan
    • ASH Directions
    • The Society Pages
  • Topic Compilations
    • COVID-19 News
    • Acute Leukemias
    • Chronic Leukemias
    • MDS & Myeloproliferative Neoplasms
    • Multiple Myeloma & Plasma Cell Disorders
    • Lymphomas & Lymphoid Neoplasia
    • Bleeding Disorders
    • Clotting Disorders
    • Red Blood Cell & Iron Disorders
  • On Location
    • ASH Annual Meeting
    • ASH Meeting on Hematologic Malignancies
    • ASH Meeting on Lymphoma Biology
    • Other Meetings
  • Multimedia
    • Sound Bites
    • Meeting Coverage
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
    Geoffrey L. Uy, MD

    Geoffrey L. Uy, MD

    Associate professor of medicine at the Washington University School of Medicine in St. Louis, Missouri
    • Should ATRA be held in a patient with acute promyelocytic leukemia and a high WBC count? Saturday, August 1st, 2015

      This month, Geoffrey L. Uy, MD, answers a question about white blood cell counts in a patient being treated for acute promyelocytic leukemia.

    admin
    Advertisement

    Current Issue

    January 2021 Annual Meeting Edition

    Friday, January 15, 2021
    This issue features highlights from the 2020 ASH Annual Meeting, a look at patient holiday gift customs around the world, and more.

    Block title

    January 2021 Annual Meeting Edition

    Friday, January 15, 2021

    FDA Approves Ponatinib for Chronic-Phase CML

    Friday, January 15, 2021

    Large Meta-Analysis Confirms Predictive Value of MRD Negativity in Myeloma

    Friday, January 15, 2021

    Selinexor Combination Approved for Patients with Multiple Myeloma

    Friday, January 15, 2021

    Big Ideas on Burnout: Trainees Propose System-Wide Solutions

    Friday, January 15, 2021
    Recent Posts
    • FDA Approves Ponatinib for Chronic-Phase CML
    • Large Meta-Analysis Confirms Predictive Value of MRD Negativity in Myeloma
    • Selinexor Combination Approved for Patients with Multiple Myeloma
    • Big Ideas on Burnout: Trainees Propose System-Wide Solutions

    Meeting Coverage

    MLL Associated With Worse Post-Transplant Outcomes Than Other Cytogenetic Factors

    Friday, May 1, 2020

    Study Examines Trends in Real-World Treatment Sequencing Patterns for CLL/SLL

    Sunday, March 1, 2020

    Editor's Corner

    There’s No Crime Like the Presents

    Friday, January 15, 2021

    Musical and Medical Reflections

    Friday, January 1, 2021
    2021 L Street NW, Suite 900, Washington, DC 20036
    Phone 202-776-0544 | Fax 202-776-0545
    • ASH Home
    • Research
    • Education
    • Advocacy
    • Meetings
    • Publications
    • ASH Store
    Copyright © 2020 by American Society of Hematology

    Contact Us | Terms of Service | Privacy Policy